[18F]FDG PET/CT:

Juliette Brezun1, Nicolas Aide2, Evelyne Peroux3

  • 1Department of Medical Oncology and Clinical Research Unit, Military Hospital Bégin, 94160 Saint-Mandé, France.

PubMed
概括

免疫检查点抑制剂可以改善肺癌的生存率,但需要新的方法来评估治疗反应. 像iRECIST和PET/CT成像等新标准有助于管理复杂的反应,改善患者的治疗结果.